Dr. Tariq Daouda holds a bachelor’s degree in mathematics and computer science, a Master’s degree in Machine Learning from the Université de Montréal, and a Ph.D. in Bioinformatics from the Université de Montréal. His Ph.D. thesis focused on the application of AI to the study of the adaptive immune system. Now he focuses on the application of Deep Learning for the analysis of RNA sequencing data.
Kasidet is a research technologist and runs experimental and computational pipelines for various collaborators and projects within the lab. Experimentally, Kasidet is interested in optimizing and innovating the single-cell droplet-based technology. Computationally, Kasidet is interested in the trajectory and lineage tracing analyses of single cell data.
Dr. Mazen Nasrallah is a rheumatologist at MGH who is interested in the clinical and translational analysis of rheumatic immune related adverse events of cancer immunotherapy. He is particularly interested in applying a systems-level analysis to better understand these diseases, and to translate this knowledge into more effective and targeted therapies.
Rachelly is a computational postdoc in the lab interested in integrating different single cell omics to study immunology at the system level. Specifically, Rachelly is working on jointly analyzing different tissues in the Immune Cell Atlas project.
Dr. Kamil Slowikowski is a postdoctoral scholar with Dr. Chloé Villani and Dr. Bo Li. As a computational biologist, he collaborates with Dr. Molly Thomas on the analysis of a large-scale study of biopsy tissues from patients suffering from immune checkpoint inhibitor-induced colitis.
Neal is a computational biologist utilizing single-cell -omics approaches to study the immune system in healthy and pathological states. Specifically, he is interested in understanding T cell mediated responses and how we can utilize TCR repertoire data to better understand T cell biology.
Dr. Leyre Zubiri is a medical oncologist specializing in patients receiving immunotherapy and suffering from secondary adverse events on the Severe Immunotherapy Complications service at MGH. Her PhD was focused on the liquid biopsy as a way to identify soluble tumor biomarkers in patients with malignant melanoma. She is actively engaged in the clinical and translational research effort in these patients to develop biomarkers to diagnose these toxicities earlier, allowing for appropriate management.